Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 42 |
| Active Pipeline (Recruiting Now) | 37 (19) |
| Completed vs Stopped Early | 1 / 4 (9.5%) |
| Median Closed Actual Enrollment | 41 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Riley Hospital for Children | Indianapolis, IN | 35 |
| Children's Hospital Colorado | Aurora, CO | 34 |
| Children's Hospital of Alabama | Birmingham, AL | 34 |
Indexed Multi-Center Phase II & III Protocols
| NCT Identifier | Protocol Brief Title | Phase | Status |
|---|---|---|---|
| NCT07022678 | Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia | Phase III | RECRUITING |
| NCT05711667 | A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients | Phase III | RECRUITING |
| NCT05504291 | A Study to Give Treatment Inside the Eye to Treat Retinoblastoma | Phase II | RECRUITING |
| NCT06368817 | A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | Phase II | RECRUITING |
| NCT05304585 | Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma | Phase III | RECRUITING |
Explore interactive annual charts and M&A subsidiary rollups in the Children's Oncology Group Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.